E-Cigarettes Increasingly Popular with Teens

E-Cigarette use has risen sharply over the past few years, as reported by the New York Times. E-cigarette use has tripled among middle and high school students from 2013 to 2014. According to federal data released today, 13% of high school students smoke e-cigarettes. As our T&T blog has reported on in the past, the Food and Drug Administration (FDA) …

Bellwether Trial Begins in St. Louis over Pfizer’s Zoloft

On Thursday, April 9, 2015, trial began in St. Louis, Missouri over Pfizer’s Zoloft, the company’s antidepressant drug, before Circuit Court Judge Margaret Neill. The Plaintiffs, Logyn Pesante and his mother Kristyn Pesante, allege that Zoloft caused Logyn Pesante to be born with multiple heart defects including TGA, or transposition of the arteries. Since birth, Logyn has undergone 25 procedures …

Dialysis GranuFlo Litigation Update

The T&T blog has reported on the Dialysis Litigation in the past as T&T represents hundreds of clients who were injured as a result of Fresenius Medical Care use of GranuFlo and NaturaLyte. Here is an update for all of our dialysis clients out there: The first bellwether trails for the Dialysis Litigation is scheduled for January 11th, 2016, with …

1st Federal Depakote Bellwether Trial Continues in St. Louis by Legal Dream Team

On March 2, 2015, a legal dream team, including John Eddie Williams, Phillip Sampson, and Tommy Fibich, assembled in federal court in the Southern District of Illinois in an attempt to expose pharmaceutical giant Abbott Labs about the dangers of taking Depakote while pregnant.  Abbott Labs marketed Depakote as an effective drug for treating epilepsy, bipolar disorders, and migraines. Unfortunately, …

Study Shows Teens Easily Purchase E-Cigarettes Over the Internet

March 2015’s issue of JAMA Pediatrics published a study entitled “Electronic Cigarette Sales to Minors via the Internet.” From February to June 2014, 11 teenagers from North Carolina ranging from 14 to 17 years old made supervised e-cigarette purchase attempts from 98 Internet e-cigarette vendors. The results are not a surprise to anyone who has used the internet to purchase …

Judge Rules in Favor of DOJ in American Express Case

Many news outlets including The New York Times, Bloomberg, and USA Today are reporting that after a seven-week trial U.S. Federal District Judge Garaufis ruled in favor of the DOJ in its claim that American Express violated U.S. anti-trust laws.  In the 150-page opinion, Garaufis wrote how American Express successfully pressured merchants into using its credit card despite being more expensive than …

J&J Drops Plaintiff Solicitation Discovery Bid In Mesh MDL

Johnson & Johnson has withdrawn its discovery motion to pursue its allegations that the plaintiffs’ attorneys in transvaginal mesh multidistrict litigation had engaged in illegal plaintiff solicitation and filed lawsuits without legitimate claims. U.S. District Judge Joseph Goodwin on Feb. 11 granted J&J’s motion to withdraw its discovery motion related to its claims of plaintiff solicitation, though it did not …

Takeda Told to Pay Punitive Damages in Actos Claims

A jury ordered Takeda Pharmaceutical Co. to pay $1.3 million in punitive damages to a former teacher who argued the drugmaker’s Actos diabetes medicine caused his bladder cancer, in the company’s fifth loss in trials over the drug. Jurors in state court in Philadelphia deliberated more than two hours Friday before concluding that Osaka, Japan-based Takeda must pay the punitive …

Takeda Ordered to Pay Damages to Actos User

Takeda Pharmaceutical Co. was ordered by a jury Thursday to pay more than $2.3 million in damages to a former teacher who blamed the company’s Actos diabetes drug for causing his bladder cancer. Jurors in state court in Philadelphia deliberated more than eight hours over two days before finding that Osaka, Japan-based Takeda failed to properly warn John Kristufek’s doctors …

Pa. Judge Won’t Strike Actos Verdict Against Takeda

Pennsylvania judge has declined to overturn a $2 million verdict awarded in October to a plaintiff who claimed that the Takeda Pharmaceuticals Inc. drug Actos was a significant contributor to her developing bladder cancer. In an order docketed on Friday, Philadelphia Court of Common Pleas Judge Shelly Robins New rejected the company’s post-trial motions, in which they had argued that …

Calif. Dept. of Health Says Tobacco Laws Should Cover E-Cigarettes

The California Department of Public Health said Wednesday (1/29/15) that laws aimed at protecting children and the public from traditional tobacco products should be expanded so that they include e-cigarettes, just one recommendation from a new report detailing the dangers and toxicity of so-called vaping devices. The report warns that the nicotine in e-cigarettes is just as addictive as in traditional …

Studies Show Depakote During Pregnancy Linked to Autism

A Danish study found that mothers who took the anti-seizure medication Depakote during pregnancy were five times as likely to give birth to a child diagnosed with autism as mothers who did not take the drug. The study monitored over 665,000 Danish children from 1996 to 2006, 5, 500 of whom were diagnosed with autism. Of these, 508 were born …

FDA Still Not Regulating E-Cigarettes

Electronic cigarettes, battery-powered devices that convert a solution of nicotine and other chemicals into a vapor that can be inhaled, or “vaped,” have the potential to wean a vast number of smokers off cigarettes. No burned tobacco leaves, no cancer-causing tar: a seemingly public health revolution in waiting. Right?  Um, not so fast. There’s the inaccurate inaccurate labeling, shoddy counterfeits and …

Actos Caused Consumer’s Bladder Cancer, Philly Jury Hears

A Philadelphia jury heard opening arguments on Wednesday in a case against Takeda Pharmaceutical Co., the latest in a string of suits against the drugmaker, alleging that a retired high-school teacher developed bladder cancer after taking the diabetes drug Actos. Miller Firm LLC attorney Michael Miller told the jury that warnings issued beginning in June 2011 about the risks associated …

60 Mesh Cases to Head to Trial

After a California court of appeals upheld a $5.5 million mesh verdict against C.R. Bard in November, the U.S District Court for the Southern District of West Virginia designated 60 vaginal mesh cases as “Miniwave 1” cases. These 60 cases will be tried in federal district courts around the country.  After the Southern District of West Virginia Court’s order, these 60 …

Texas Legislature to Consider Banning E-Cigarette Sales to Minors

From The Houston Chronicle: Legislators in Texas, one of just nine states that permit the sale of e-cigarettes to minors, will consider banning such sales amid concerns about growing use of the “safer” alternative to smoking among youth. Even as the Texas Medical Association and Texas Public Health Coalition plan to lobby the 2015 Legislature to regulate e-cigarettes, three bills …

Survey Finds Teens Trending Toward E-cigarettes

More teens are trying out e-cigarettes than the real thing, according to the government’s annual drug use survey. Researchers were surprised at how many 8th, 10th and 12th graders reported using electronic cigarettes this year, even as regular smoking by teens dropped to new lows. Nearly 9 percent of 8th graders said they had used an e-cigarette in the previous …

CDC Reports Tanning Bed Injuries Nearly 2,000 in 2012

Enter an indoor tanning booth today and you may find yourself with skin cancer decades down the road. But some painful consequences could be immediate. An estimated 1,957 indoor tanners landed in U.S. emergency rooms in 2012 after burning their skin or eyes, fainting or suffering other injuries, researchers from the federal Centers for Disease Control and Prevention reported Monday. …

Back-to-Back Transvaginal Mesh Trial Losses Put Pressure on Boston Scientific

Boston Scientific Corp’s back-to-back losses in the first two federal trials over its transvaginal mesh devices could drive up the cost of resolving thousands of similar lawsuits, according to legal experts. On November 20th, a jury in West Virginia awarded four women $18.5 million for injuries they said were caused by the Massachusetts-based company’s Obtryx device for stress urinary incontinence, …

Eli Lilly, Takeda Win Dismissal Of Ark. Taxpayer Actos Suit

A Louisiana federal judge on Thursday threw out a proposed class action alleging that Takeda Pharmaceutical Co. and Eli Lilly & Co. ripped off taxpayers by hiding the risks of their diabetes drug Actos, after the Arkansas Supreme Court ruled the drug was properly prescribed by doctors. In a two-page order granting the defendant’s motion to dismiss for failure to …

Bard Can’t Avoid Its Part Of Pelvic Mesh Verdict

  A California appeals court on Wednesday affirmed a $5.5 million verdict against C.R. Bard Inc. and a gynecologist that found the two responsible for a woman’s injuries from a vaginal mesh implant in the first such case to go to trial. The panel rejected Bard’s argument that the negligence theories submitted to the jury were erroneous, finding instead that …

Takeda Ordered to Pay for Destroying Actos Files

Bloomberg is reporting that Takeda Pharmaceutical was ordered by a jury to pay $155,000 over its destruction of documents about its Actos diabetes medicine after the panel concluded the missing files blocked a man from proving his claims that the drug caused his cancer. Jurors in state court in Martinsburg, West Virginia, deliberated about three hours today before concluding Takeda …

The Health Claims Of E-Cigarettes Are Going Up In Smoke

The sales pitch of electronic cigarette manufacturers seemed too good to be true. Could nicotine addicts around the world really get their fix whilst dodging the health risks of puffing away on cancer sticks? Sadly for smokers and “vapers,” the answer is far from clear. New evidence has emerged which suggests that E-Cigarettes can be dangerous too – in some …

It’s Easy to Overdose on Tylenol, Study Warns

The rise in prescriptions and non-prescription use of painkillers in the U.S. is no secret – in the past decade, prescriptions for opioids have skyrocketed by 300%, making them the most prescribed drugs in the country. And the consequences of that spike can be deadly, according to the latest report from Consumer Reports: nearly 17,000 people die each year from …

Stryker Agrees to Pay in Settlement for Hip Implant Suits

Stryker Corp. agreed to pay more than $1 billion to resolve lawsuits over thousands of hip implants recalled in 2012 after patients complained of pain, swelling and metal debris from the devices. Stryker will pay a base amount of $300,000 per case to patients who had the devices surgically removed, Kim Catullo, one of the company’s lawyers, told a New …

J&J considering Settling Defective Hip Suit

Johnson & Johnson may pay more than $250 million to resolve suits over its ASR hip implants that were excluded from a $2.5 billion settlement of similar claims last year over the device’s failure, two people familiar with the accord said. J&J, the world’s largest seller of health-care products, is weighing whether to settle more than 1,000 lawsuits over removals …

Actos Update: Takeda Lowers Punitive Damages Penalty

Takeda Pharmaceutical Co. and Eli Lilly & Co. won a more than a 99 percent cut in a $9 billion punitive damages award over claims the drugmakers hid the cancer risks of their Actos diabetes medicine. Jurors properly found officials of Osaka, Japan-based Takeda and Indianapolis-based Lilly intentionally hid the health risks of the drug and should pay punitive damages, …

Boston Scientific Puts Aside Funds to Pay for Legal Expenses

Facing ongoing lawsuits over mesh products used to treat urinary incontinence, its 2006 acquisition of Guidant Corp., and tax issues with the IRS, Boston Scientific has now set aside nearly $1 billion to pay legal expenses. The Marlborough-based medical device company increased its litigation reserves by $139 million over the course of the three months that ended in September to …

First Actos Bladder Cancer Suit In W.Va. Goes To Trial

The first trial in West Virginia state court over allegations that Takeda Pharmaceutical Co. Ltd.’s widely prescribed diabetes drug Actos causes bladder cancer begins today, featuring the same plaintiffs firm that has taken Actos cases to trial in four other states and secured three pro-plaintiff verdicts. The West Virginia trial comes shortly after the Miller Firm LLC secured a $2 …

Update: Takeda Ordered to Pay Actos User After Verdict is Reached

As mentioned in previous blog posts, we continue to follow the Actos bellwether trials as they occur across the country.  The latest Actos verdict occurred in Philadelphia, PA. in favor of the injured plaintiff. Takeda Pharmaceutical Co. was ordered by a jury to pay more than $2 million to a woman who claimed the company’s Actos diabetes medicine caused her bladder …

Takeda Accused of Putting Actos Profit Ahead of Safety

Takeda Pharmaceutical Co. was accused by a lawyer for a woman who blames Actos for her cancer of sacrificing safety for profit by failing to warn patients and doctors about the diabetes medicine’s risks. Executives at Osaka, Japan-based Takeda knew by 2004 that studies found links between Actos and cancer, and didn’t issue a warning until seven years later to …

Endo to Settle Legal Claims Concerning Vaginal Mesh Products

Endo International PLC said it reached agreements to settle substantially all of the claims concerning vaginal mesh products sold by its American Medical Systems Holding Inc. unit. The drug and medical-device company said the agreements aren’t an admission of liability or fault. In April, Endo said it would pay about $830 million before taxes to settle a “substantial majority” of …

Good News: Takeda Hid Actos Bladder Cancer Risks, Philly Jury Hears

  An expert witness testifying on behalf of a woman who claims she developed bladder cancer after taking the diabetes drug Actos told a Philadelphia jury on Thursday that Takeda Pharmaceuticals Co. Ltd. had worked to suppress information about the cancer risks associated with the medication. Randall Tackett, a pharmacologist and toxicologist at the University of Georgia tapped to testify …

AAA Study Says 3 of 4 Kids’ Seats Are Installed Wrong

How safe is YOUR child’s safety seat? According to a new AAA survey, chances are it is not as safe as you thought. “Three out of four car seats today are installed incorrectly,” said Michele Harris, director of traffic safety culture, AAA – The Auto Club Group. “Too often, we see kids who are in a car seat that’s installed …

5 Ways Tech Improves Car Safety

 DETROIT – Cellphones that warn drivers when people are crossing in front of them. Bicycles and cars that communicate with traffic lights. Sensors in cars that quickly alert other drivers to black ice, potholes or other hazards. A low-priced camera system that brings high-tech automatic braking to the masses. These life- or time-saving technologies are being shown off this week …

Boston Scientific Hit With Verdict In 1st Pelvic Mesh Loss

A Texas state jury blasted Boston Scientific Corp. with a $73.4 million verdict on Monday, finding that the company’s Obtryx-brand transvaginal sling was defectively designed and caused severe injuries, marking the first time the company has not prevailed in litigation over its pelvic mesh products. A spokeswoman from the law firm Freese & Goss, which represented plaintiff Martha Salazar, confirmed …

Judge Plans To Speed Up Vaginal Mesh Lawsuits, Trials

As the number of vaginal mesh lawsuits filed throughout the federal court system continues to increase, with many of the manufacturers of these controversial products making little progress toward settling the claims, the U.S. District Judge presiding over the litigation indicates that he will prepare a large number of cases to be “expeditiously set for trial.” U.S. District Judge Joseph …

FDA Doesn’t Man Up: Fails to Recall Vagina Mesh

The U.S. Food and Drug Administration has rejected a request from advocacy group Public Citizen to order recalls of existing surgical mesh products and ban their future sale, according to a letter released Monday that said a recent proposal to more rigorously review the devices is sufficient for now. In its response to a 2011 petition from Public Citizen, the …